MRCF establishes life science incubator to boost NZ startup successes
QUE Oncology recruiting Sydney breast cancer patients experiencing hot flushes & night sweats
$14m invested in University of Melbourne spin-out to create vaccine for periodontal gum disease
FDA Grants EBR Systems Breakthrough Device Designation Status for the WiSE Cardiac Resynchronization Therapy (CRT) System
Perth tech joint-winner in global finals for international start-up competition
EBR Systems Closes $30M in New Funding, John McCutcheon Joins Company as President and CEO
Q-Sera’s innovative blood clotting technology granted patent in US
QUE Oncology launches Phase II trials in New Zealand
QUE Oncology Appoints Dr. Julie Cherrington and Elizabeth Cermak to Board of Directors
PolyActiva completes recruitment in key Phase I glaucoma implant safety study.
Morphoseq™ at ‘Sequencing, Finishing and Analysis in the Future’ meeting, USA
Longas Launches, Unveiling Morphoseq™ Long Read DNA Sequencing Technology
Brandon Capital Partners launches new Medical Research Commercialisation Fund, seeks NZ institutional
QUE Oncology launches Phase II trials in the United States
MRCF launches Perth-based biotech developing new treatment for Cystic Fibrosis
Aravax reveals positive Phase I trial results at world-leading allergy conference
Australian Phase II trial commences for potential world-first treatment of viral conjunctivitis
